Published in Am J Respir Crit Care Med on February 04, 2010
An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med (2011) 5.53
Biomarker-based asthma phenotypes of corticosteroid response. J Allergy Clin Immunol (2014) 2.74
Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients. J Allergy Clin Immunol (2012) 2.24
Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects. J Allergy Clin Immunol (2013) 1.80
Severe asthma: lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program. Am J Respir Crit Care Med (2011) 1.76
Gene expression in relation to exhaled nitric oxide identifies novel asthma phenotypes with unique biomolecular pathways. Am J Respir Crit Care Med (2014) 1.69
Predicting asthma exacerbations in children. Curr Opin Pulm Med (2012) 1.24
Nitric oxide and related enzymes in asthma: relation to severity, enzyme function and inflammation. Clin Exp Allergy (2011) 1.23
Cardiovascular biomarkers in exhaled breath. Prog Cardiovasc Dis (2012) 1.09
The BELFRAIL (BFC80+) study: a population-based prospective cohort study of the very elderly in Belgium. BMC Geriatr (2010) 1.01
Development of New Therapies for Severe Asthma. Allergy Asthma Immunol Res (2017) 0.94
Diagnostic accuracy of the bronchodilator response in children. J Allergy Clin Immunol (2013) 0.93
Advances in pediatric asthma in 2010: addressing the major issues. J Allergy Clin Immunol (2011) 0.90
Update in asthma 2011. Am J Respir Crit Care Med (2012) 0.89
Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling study. Respir Res (2015) 0.87
Characterization of factors associated with systemic corticosteroid use in severe asthma: data from the Severe Asthma Research Program. J Allergy Clin Immunol (2013) 0.86
Metabolomic Endotype of Asthma. J Immunol (2015) 0.85
Emerging molecular phenotypes of asthma. Am J Physiol Lung Cell Mol Physiol (2014) 0.85
Severe asthma in childhood: recent advances in phenotyping and pathogenesis. Curr Opin Allergy Clin Immunol (2012) 0.84
Effect of nanoparticles exposure on fractional exhaled nitric oxide (FENO) in workers exposed to nanomaterials. Int J Mol Sci (2014) 0.83
Elevated levels of NO are localized to distal airways in asthma. Free Radic Biol Med (2011) 0.82
Epigenetic regulation: the interface between prenatal and early-life exposure and asthma susceptibility. Environ Mol Mutagen (2013) 0.81
A mobile instrumentation platform to distinguish airway disorders. J Breath Res (2013) 0.81
Update in asthma 2010. Am J Respir Crit Care Med (2011) 0.81
Nitric oxide in asthma physiopathology. ISRN Allergy (2011) 0.80
Biomarkers in asthma: a real hope to better manage asthma. Clin Chest Med (2012) 0.80
Exhaled nitric oxide and clinical phenotypes of childhood asthma. Respir Res (2011) 0.80
Biomarkers in airway diseases. Can Respir J (2013) 0.79
Clinical Implications of Having Reduced Mid Forced Expiratory Flow Rates (FEF25-75), Independently of FEV1, in Adult Patients with Asthma. PLoS One (2015) 0.79
Biomarkers and severe asthma: a critical appraisal. Clin Mol Allergy (2015) 0.79
Relationships between airway hyperresponsiveness, inflammation, and calibre in asthma. Lung (2011) 0.78
Oxidative stress and lung function profiles of male smokers free from COPD compared to those with COPD: a case-control study. Libyan J Med (2014) 0.78
Soluble guanylate cyclase as an alternative target for bronchodilator therapy in asthma. Proc Natl Acad Sci U S A (2016) 0.77
Severe Asthma in Children: Lessons Learned and Future Directions. J Allergy Clin Immunol Pract (2016) 0.77
Exhaled Nitric Oxide Levels Among Adults With Excessive Alcohol Consumption. Chest (2016) 0.77
Imaging pulmonary inducible nitric oxide synthase expression with PET. J Nucl Med (2014) 0.77
Gene Expression Correlated to Severe Asthma Characteristics Reveals Heterogeneous Mechanisms of Severe Disease. Am J Respir Crit Care Med (2016) 0.77
Severe Asthma: The Evolution of Patient-directed Management. Clin Pulm Med (2014) 0.76
Nitric oxide and asthma severity: towards a better understanding of asthma phenotypes. Clin Exp Allergy (2012) 0.76
The Clinical and Health Economic Value of Clinical Laboratory Diagnostics. EJIFCC (2015) 0.75
Chinese expert consensus on clinical use of non-invasive airway inflammation assessment in bronchial asthma. Ann Transl Med (2015) 0.75
Role of exhaled nitric oxide as a predictor of atopy. Respir Res (2013) 0.75
Longitudinal stability of asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) study. Respir Res (2016) 0.75
Chinese expert consensus on clinical use of non-invasive airway inflammation assessment in bronchial asthma. J Thorac Dis (2015) 0.75
Early life microbial exposure and fractional exhaled nitric oxide in school-age children: a prospective birth cohort study. Environ Health (2013) 0.75
Biomarkers for the Phenotyping and Monitoring of Asthma in Children. Curr Treat Options Allergy (2016) 0.75
Gender Differences in Respiratory Health of School Children Exposed to Rail Yard-Generated Air Pollution: The ENRRICH Study. J Environ Health (2016) 0.75
Mind-body interactions in the regulation of airway inflammation in asthma: A PET study of acute and chronic stress. Brain Behav Immun (2016) 0.75
Clinical Utility of Fractional exhaled Nitric Oxide (FeNO) as a Biomarker to Predict Severity of Disease and Response to Inhaled Corticosteroid (ICS) in Asthma Patients. J Clin Diagn Res (2016) 0.75
Respiratory Health Risks for Children Living Near a Major Railyard. J Community Health (2015) 0.75
Arginine metabolic endotypes related to asthma severity. PLoS One (2017) 0.75
Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med (1995) 33.41
Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society. Am Rev Respir Dis (1991) 13.67
ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med (2005) 11.34
An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med (2009) 9.38
Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet (2002) 8.57
Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. Am J Respir Crit Care Med (2000) 8.09
Standardisation of the measurement of lung volumes. Eur Respir J (2005) 7.48
Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med (2005) 6.96
Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol (2007) 6.33
Increased nitric oxide in exhaled air of asthmatic patients. Lancet (1994) 5.39
Asthma: defining of the persistent adult phenotypes. Lancet (2006) 4.78
Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med (1999) 4.75
The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. European Network for Understanding Mechanisms of Severe Asthma. Eur Respir J (2003) 4.08
Reference values for residual volume, functional residual capacity and total lung capacity. ATS Workshop on Lung Volume Measurements. Official Statement of The European Respiratory Society. Eur Respir J (1995) 3.27
Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am J Respir Cell Mol Biol (1993) 3.20
Protection from experimental asthma by an endogenous bronchodilator. Science (2005) 3.17
Nitric oxide in health and disease of the respiratory system. Physiol Rev (2004) 3.15
Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J (2006) 3.09
Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Respir Crit Care Med (2001) 2.87
"Refractory" eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids. Am J Respir Crit Care Med (2004) 2.77
Bronchodilator S-nitrosothiol deficiency in asthmatic respiratory failure. Lancet (1998) 2.47
Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension. FASEB J (2004) 2.37
NO chemical events in the human airway during the immediate and late antigen-induced asthmatic response. Proc Natl Acad Sci U S A (2001) 2.33
Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med (1996) 2.32
Features of severe asthma in school-age children: Atopy and increased exhaled nitric oxide. J Allergy Clin Immunol (2006) 2.30
Single-breath nitric oxide measurements in asthmatic patients and smokers. Lancet (1994) 2.28
Dose-response relationship and reproducibility of the fall in exhaled nitric oxide after inhaled beclomethasone dipropionate therapy in asthma patients. Chest (2001) 1.92
Factors associated with persistent airflow limitation in severe asthma. Am J Respir Crit Care Med (2001) 1.88
Severe asthma in adults: what are the important questions? J Allergy Clin Immunol (2007) 1.85
Molecular mechanisms of increased nitric oxide (NO) in asthma: evidence for transcriptional and post-translational regulation of NO synthesis. J Immunol (2000) 1.84
Pathophysiology of severe asthma. J Allergy Clin Immunol (2000) 1.80
Fraction of exhaled nitric oxide at 50 mL/s: reference values for adult lifelong never-smokers. Chest (2007) 1.80
Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests. Am J Respir Crit Care Med (2003) 1.74
Correlation of systemic superoxide dismutase deficiency to airflow obstruction in asthma. Am J Respir Crit Care Med (2005) 1.72
Expired nitric oxide levels during treatment of acute asthma. Am J Respir Crit Care Med (1995) 1.71
Nitric oxide synthesis in the lung. Regulation by oxygen through a kinetic mechanism. J Clin Invest (1998) 1.60
Enhanced superoxide production by alveolar macrophages and air-space cells, airway inflammation, and alveolar macrophage density changes after segmental antigen bronchoprovocation in allergic subjects. Am Rev Respir Dis (1992) 1.57
Nitrative stress in refractory asthma. J Allergy Clin Immunol (2007) 1.53
Acid stress in the pathology of asthma. J Allergy Clin Immunol (2004) 1.45
Rapid loss of superoxide dismutase activity during antigen-induced asthmatic response. Lancet (2000) 1.43
Effect of inhaled budesonide on lung function and airway inflammation. Assessment by various inflammatory markers in mild asthma. Am J Respir Crit Care Med (1999) 1.42
Contribution of nitric oxide synthases 1, 2, and 3 to airway hyperresponsiveness and inflammation in a murine model of asthma. J Exp Med (1999) 1.38
NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependent childhood asthma. Eur Respir J (1999) 1.36
Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-naive patients with mild asthma. Am J Respir Crit Care Med (1998) 1.36
Elastic recoil of the lungs in chronic asthmatic patients before and after therapy. J Appl Physiol (1967) 1.32
Expired nitric oxide after bronchoprovocation and repeated spirometry in patients with asthma. Am J Respir Crit Care Med (1998) 1.22
Airway nitric oxide diffusion in asthma: Role in pulmonary function and bronchial responsiveness. Am J Respir Crit Care Med (2000) 1.19
Genetic variation in S-nitrosoglutathione reductase (GSNOR) and childhood asthma. J Allergy Clin Immunol (2007) 1.17
Exhaled nitric oxide in patients with asthma: association with NOS1 genotype. Am J Respir Crit Care Med (2000) 1.16
Elevated nitric oxide concentrations in isolated lower airway gas of asthmatic subjects. Am J Respir Crit Care Med (1996) 1.14
Temporal association of nitric oxide levels and airflow in asthma after whole lung allergen challenge. J Appl Physiol (1985) (2003) 1.12
Asthma phenotypes. Curr Opin Pulm Med (2007) 1.10
The static elastic properties of the lungs in asthma. Am Rev Respir Dis (1968) 1.05
Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal. Am J Respir Crit Care Med (1999) 0.95
Nitric oxide regulation of asthmatic airway inflammation with segmental allergen challenge. J Allergy Clin Immunol (1999) 0.93
Phenotypes in asthma: useful guides for therapy, distinct biological processes, or both? Am J Respir Crit Care Med (2004) 0.91
Changes in total lung capacity during acute spontaneous asthma. Am Rev Respir Dis (1990) 0.90
Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma. Eur Respir J (2008) 0.90
A neuronal NO synthase (NOS1) gene polymorphism is associated with asthma. Biochem Biophys Res Commun (2000) 0.89
Exhaled nitric oxide reflects asthma severity and asthma control. Pediatr Crit Care Med (2004) 0.81
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J (2013) 8.39
Genetic epidemiology of COPD (COPDGene) study design. COPD (2010) 7.67
Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med (2005) 7.61
Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med (2009) 7.17
Nurse training in sexual and reproductive health. J Fam Plann Reprod Health Care (2010) 6.34
Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol (2007) 6.33
Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med (2010) 6.19
A chitinase-like protein in the lung and circulation of patients with severe asthma. N Engl J Med (2007) 6.02
Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med (2009) 5.90
Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med (2012) 5.54
An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med (2011) 5.53
Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial. Am J Respir Crit Care Med (2009) 4.83
Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat Med (2008) 4.70
Active albuterol or placebo, sham acupuncture, or no intervention in asthma. N Engl J Med (2011) 4.68
Respiratory effects of exposure to diesel traffic in persons with asthma. N Engl J Med (2007) 4.58
Randomized comparison of strategies for reducing treatment in mild persistent asthma. N Engl J Med (2007) 4.40
Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol (2010) 4.38
GOLD 2011 disease severity classification in COPDGene: a prospective cohort study. Lancet Respir Med (2012) 3.98
A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma. Am J Respir Crit Care Med (2007) 3.83
Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations. Nat Genet (2011) 3.68
Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol (2002) 3.66
Lansoprazole for children with poorly controlled asthma: a randomized controlled trial. JAMA (2012) 3.40
Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol (2007) 3.28
Nitric oxide in health and disease of the respiratory system. Physiol Rev (2004) 3.15
Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol (2010) 3.12
A randomized, controlled, phase 2 study of AMG 317, an IL-4Ralpha antagonist, in patients with asthma. Am J Respir Crit Care Med (2010) 3.11
NHS to receive an extra 40bn pound sterling over next five years. BMJ (2002) 3.10
Wanless report outlines "Rolls- Royce" health service for 2022. BMJ (2002) 3.04
Detection of lung cancer by sensor array analyses of exhaled breath. Am J Respir Crit Care Med (2005) 2.94
Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation. J Appl Physiol (1985) (2007) 2.83
Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med (2007) 2.81
Efficacy of a new once-daily long-acting inhaled beta2-agonist indacaterol versus twice-daily formoterol in COPD. Thorax (2010) 2.79
The mouse trap: It still yields few answers in asthma. Am J Respir Crit Care Med (2006) 2.68
An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension. Nat Med (2012) 2.59
Natural killer T cells in the lungs of patients with asthma. J Allergy Clin Immunol (2009) 2.57
A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma. Am J Respir Crit Care Med (2009) 2.56
Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity. Proc Natl Acad Sci U S A (2004) 2.55
Expression and activity of pH-regulatory glutaminase in the human airway epithelium. Am J Respir Crit Care Med (2002) 2.54
beta-Adrenergic receptor polymorphisms and response to salmeterol. Am J Respir Crit Care Med (2005) 2.45
Alterations of cellular bioenergetics in pulmonary artery endothelial cells. Proc Natl Acad Sci U S A (2007) 2.44
Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma. J Allergy Clin Immunol (2007) 2.43
A multivariate analysis of risk factors for the air-trapping asthmatic phenotype as measured by quantitative CT analysis. Chest (2008) 2.38
Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension. FASEB J (2004) 2.37
Diet-induced weight loss, exercise, and chronic inflammation in older, obese adults: a randomized controlled clinical trial. Am J Clin Nutr (2004) 2.37
Prospective, randomized, controlled trial between a pathway of controlled rehabilitation with early ambulation and diet and traditional postoperative care after laparotomy and intestinal resection. Dis Colon Rectum (2003) 2.34
Blocking airway mucous cell metaplasia by inhibiting EGFR antiapoptosis and IL-13 transdifferentiation signals. J Clin Invest (2006) 2.33
Features of severe asthma in school-age children: Atopy and increased exhaled nitric oxide. J Allergy Clin Immunol (2006) 2.30
Use of infliximab within 3 months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn's patients. J Gastrointest Surg (2008) 2.29
Heterogeneity of severe asthma in childhood: confirmation by cluster analysis of children in the National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program. J Allergy Clin Immunol (2010) 2.27
Determinants of asthma after severe respiratory syncytial virus bronchiolitis. J Allergy Clin Immunol (2012) 2.27
Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study. Am J Respir Crit Care Med (2013) 2.25
Changing patterns in asbestos-induced lung disease. Chest (2004) 2.24
Design and baseline characteristics of the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol (2004) 2.22
Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes. J Allergy Clin Immunol (2010) 2.20
High eosinophil count: a potential biomarker for assessing successful omalizumab treatment effects. J Allergy Clin Immunol (2013) 2.14
Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids. Hum Mol Genet (2004) 2.14
The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation. J Allergy Clin Immunol (2005) 2.11
Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness. J Immunol (2007) 2.11
BMA negotiator calls for more male medical students. BMJ (2002) 2.10